Free Trial

LENSAR (LNSR) Competitors

LENSAR logo
$13.98 0.00 (0.00%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$13.36 -0.63 (-4.47%)
As of 05/22/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LNSR vs. RXST, BBNX, CBLL, DCTH, AVNS, BFLY, BVS, KIDS, NPCE, and AXGN

Should you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include RxSight (RXST), Beta Bionics (BBNX), CeriBell (CBLL), Delcath Systems (DCTH), Avanos Medical (AVNS), Butterfly Network (BFLY), Bioventus (BVS), OrthoPediatrics (KIDS), NeuroPace (NPCE), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry.

LENSAR vs.

RxSight (NASDAQ:RXST) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, community ranking, media sentiment, profitability, analyst recommendations, risk and valuation.

RxSight currently has a consensus price target of $37.90, suggesting a potential upside of 138.51%. LENSAR has a consensus price target of $15.00, suggesting a potential upside of 7.30%. Given RxSight's stronger consensus rating and higher possible upside, equities research analysts clearly believe RxSight is more favorable than LENSAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RxSight
2 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.30
LENSAR
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

LENSAR has lower revenue, but higher earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RxSight$148.31M4.35-$48.61M-$0.67-23.72
LENSAR$57.07M2.89-$14.38M-$4.85-2.88

RxSight has a net margin of -23.92% compared to LENSAR's net margin of -34.03%. RxSight's return on equity of -14.00% beat LENSAR's return on equity.

Company Net Margins Return on Equity Return on Assets
RxSight-23.92% -14.00% -12.51%
LENSAR -34.03%-49.02%-21.12%

RxSight has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.

RxSight received 46 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 63.41% of users gave RxSight an outperform vote while only 37.50% of users gave LENSAR an outperform vote.

CompanyUnderperformOutperform
RxSightOutperform Votes
52
63.41%
Underperform Votes
30
36.59%
LENSAROutperform Votes
6
37.50%
Underperform Votes
10
62.50%

78.8% of RxSight shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 9.4% of RxSight shares are owned by insiders. Comparatively, 38.5% of LENSAR shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, RxSight had 16 more articles in the media than LENSAR. MarketBeat recorded 16 mentions for RxSight and 0 mentions for LENSAR. LENSAR's average media sentiment score of 1.67 beat RxSight's score of 1.48 indicating that LENSAR is being referred to more favorably in the news media.

Company Overall Sentiment
RxSight Positive
LENSAR Very Positive

Summary

RxSight beats LENSAR on 14 of the 18 factors compared between the two stocks.

Get LENSAR News Delivered to You Automatically

Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LNSR vs. The Competition

MetricLENSARSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$164.85M$4.43B$5.33B$8.39B
Dividend YieldN/A43.63%5.21%4.11%
P/E Ratio-9.5829.0826.8019.71
Price / Sales2.8970.54397.78120.67
Price / CashN/A51.0838.2534.62
Price / Book4.716.196.774.50
Net Income-$14.38M$67.60M$3.23B$248.22M
7 Day Performance-0.92%-1.43%0.48%-0.78%
1 Month Performance1.01%15.75%9.13%11.53%
1 Year Performance237.68%22.01%18.58%8.99%

LENSAR Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LNSR
LENSAR
1.0624 of 5 stars
$13.98
flat
$15.00
+7.3%
+236.9%$164.85M$57.07M-9.58110High Trading Volume
RXST
RxSight
2.9865 of 5 stars
$16.32
+15.0%
$37.90
+132.2%
-74.3%$663.20M$148.31M-19.66220Positive News
High Trading Volume
BBNX
Beta Bionics
N/A$15.10
+5.2%
$24.83
+64.5%
N/A$654.68M$69.83M0.00294
CBLL
CeriBell
2.7184 of 5 stars
$17.83
-0.8%
$32.50
+82.3%
N/A$644.43M$71.54M0.00N/APositive News
DCTH
Delcath Systems
3.095 of 5 stars
$18.10
+5.8%
$22.75
+25.7%
+105.7%$630.35M$53.85M-13.4160Positive News
AVNS
Avanos Medical
2.6576 of 5 stars
$13.00
-0.8%
N/A-38.6%$601.17M$689.20M38.244,040Positive News
BFLY
Butterfly Network
2.615 of 5 stars
$2.32
-1.3%
$4.00
+72.4%
+106.5%$581.13M$85.63M-5.04460Positive News
Gap Down
BVS
Bioventus
3.3085 of 5 stars
$6.93
+2.1%
$14.33
+106.8%
+3.3%$557.76M$567.70M-11.361,200Positive News
KIDS
OrthoPediatrics
4.6057 of 5 stars
$22.95
-0.5%
$35.83
+56.1%
-36.2%$557.39M$212.45M-18.66200Positive News
NPCE
NeuroPace
1.444 of 5 stars
$17.00
-2.8%
$15.00
-11.8%
+125.1%$556.80M$79.91M-17.00170Gap Down
High Trading Volume
AXGN
AxoGen
3.3902 of 5 stars
$11.76
-0.6%
$22.20
+88.8%
+76.5%$535.60M$194.52M-36.75450

Related Companies and Tools


This page (NASDAQ:LNSR) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners